← Back to Search

Device

Whole breast ultrasound for Breast Cancer (DBTUST Trial)

N/A
Waitlist Available
Led By Wendie Berg, MD, PhD
Research Sponsored by Wendie Berg
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Women aged 40 to 75 years of age with heterogeneously dense or extremely dense parenchyma by prior digital mammography report (i.e., "dense breasts"), presenting for routine annual mammography with digital breast tomosynthesis.
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 years
Awards & highlights

DBTUST Trial Summary

This study is evaluating whether a screening test can detect breast cancer in women with dense breasts.

Eligible Conditions
  • Breast Cancer

DBTUST Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

DBTUST Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Cancer Yield Per 1,000
False-positive Recall Rate
Sensitivity (True Positive Rate)
Secondary outcome measures
Types of Abnormalities Detected by Ultrasound and Tomosynthesis

DBTUST Trial Design

1Treatment groups
Experimental Treatment
Group I: Whole breast ultrasoundExperimental Treatment1 Intervention
All women will receive both 3D mammography and whole breast ultrasound for breast cancer screening; the order of interpretation will vary for each of two radiologists
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Whole breast ultrasound
2015
N/A
~6270

Find a Location

Who is running the clinical trial?

Wendie BergLead Sponsor
3 Previous Clinical Trials
3,748 Total Patients Enrolled
3 Trials studying Breast Cancer
3,748 Patients Enrolled for Breast Cancer
National Cancer Institute (NCI)NIH
13,654 Previous Clinical Trials
40,926,887 Total Patients Enrolled
939 Trials studying Breast Cancer
1,537,094 Patients Enrolled for Breast Cancer
Wendie Berg, MD, PhDPrincipal InvestigatorUniversity of Pittsburgh
3 Previous Clinical Trials
3,748 Total Patients Enrolled
3 Trials studying Breast Cancer
3,748 Patients Enrolled for Breast Cancer

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~671 spots leftby Apr 2025